The Re-analysis of LC-SCRUM-Asia Successfully Detected an Overlooked <i>ROS1</i> Fusion Gene in a Lung Adenocarcinoma Patient and Led to Proper Treatment-Reference-Cited by-同舟云学术

The Re-analysis of LC-SCRUM-Asia Successfully Detected an Overlooked ROS1 Fusion Gene in a Lung Adenocarcinoma Patient and Led to Proper Treatment

Published:2021-08-20 Issue:4 Volume:61 Page:303-309
ISSN:0386-9628
Container-title:Haigan
language:en
Short-container-title:JJLC

Author:

Kunimasa Kei¹,Matsumoto Shingo²,Nishino Kazumi¹,Kukita Yoji³,Honma Keiichiro⁴,Tamiya Motohiro¹,Inoue Takako¹,Kawamura Takahisa¹,Goto Koichi²,Kumagai Toru¹

Affiliation:

1. Department of Thoracic Oncology, Osaka International Cancer Institute

2. Department of Thoracic Oncology, National Cancer Center Hospital East

3. Laboratory of Genomic Pathology, Osaka International Cancer Institute

4. Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute

Publisher

Japan Lung Cancer Society

Subject

Pulmonary and Respiratory Medicine,Oncology

Link

https://www.jstage.jst.go.jp/article/haigan/61/4/61_303/_pdf

Reference14 articles.

1. 1. Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, et al. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. Ann Oncol. 2020; 31: 1491-1505.

2. 2. Hey SP, Gerlach CV, Dunlap G, Prasad V, Kesselheim AS. The evidence landscape in precision medicine. Sci Transl Med. 2020; 12: eaaw7745.

3. 3. Kunimasa K, Matsumoto S, Nishino K, Nakamura H, Kuhara H, Tamiya M, et al. Improvement strategies for successful next-generation sequencing analysis of lung cancer. Future Oncol. 2020; 16: 1597-1606.

4. 4. Lira ME, Choi YL, Lim SM, Deng S, Huang D, Ozeck M, et al. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer. J Mol Diagn. 2014; 16: 229-243.

5. 5. 松本慎吾. LC-SCRUM-Asiaにおける遺伝子パネル検査の現状と展望. 肺癌. 2020; 60: 456.